Elekta Ab Class B · OMXSTO:EKTA_B

Elekta Ab Class B — Elekta Analyst meeting

12 slides from Elekta Ab Class B's investor presentation, 2018

  1. Slide 1: Thought Leader in Precision Radiation Medicine

    Thought Leader in Precision Radiation Medicine Dr. Richard Hausmann President and CEO

  2. Slide 2: We are precision radiation medicine.

    We are precision radiation medicine. Everyone with cancer should have access to—and benefit from—precise, personalized radiation medicine.

  3. Slide 3: The need for Precision Radiation Medicine

    The need for Precision Radiation Medicine • •• All cancers 50.3% 67% Prostate 67.8% 98.6% Thyroid 92.1% 98.2% Improve operational •• Melanoma 81.9% 91.7% efficiency and patient • Breast (female) 74.8% 89.7% • Uterus 82.3% 86.9% experience by Bladder 72.3% 77.3% hypofractionation Kidney 50.1% Non-Hod

  4. Slide 4: MOSAIQ reducing adverse incidents by 63%

    MOSAIQ® reducing adverse incidents by 63% “Since the introduction of the OIS [MOSAIQ] combined with protocol standardization, medical incidents have reduced by 63% (P=0.0068— significant)” Medication incident reduction at Illawarra Cancer Care Centre, Cancer Services Award for Excellence in the prov

  5. Slide 5: MOSAIQ Plaza: A suite of digital tools

    MOSAIQ Plaza: A suite of digital tools, designed to power Elekta digital accelerators.

  6. Slide 6: MOSAIQ Plaza driving SmartClinic

    MOSAIQ Plaza driving SmartClinic

  7. Slide 7: Monaco HD

    Monaco HD Unlocks unique HD treatment capabilities Speed without compromise Deliver what you plan Automatically respond to change Focus where it matters. MOSAIQ Plaza is not available in all Markets

  8. Slide 8: Integrated Monaco HD / MOSAIQ Plaza user experience

    Integrated Monaco HD / MOSAIQ Plaza user experience Significant reduction in time required for administration and daily planning ® Monaco MOSAIQ ® Demographic Common-user Patient Automated plan SRO managed Isocenter Sharing Authorization Access Log export/promotion in Monaco shifts PRO LPTXX181212 F

  9. Slide 9: The tumor has nowhere to hide.

    The tumor has nowhere to hide.

  10. Slide 10: 6 months of clinical experience with Elekta Unity

    6 months of clinical experience with Elekta Unity 7 clinical sites Treated cases mBeam DWI >160 patients ~60 papers at ESTRO Focus where it matters. DWI is intended for imaging purposes only and is only CE marked for brain applications. Images courtesy of NKI-AvL. Please note this information is for

  11. Slide 11: Q&A

    ©Elekta Q&A Focus where it matters.

  12. Slide 12: Elekta Discovery Zone

    Elekta Discovery Zone SATURDAY SUNDAY MONDAY Time Topic Time Topic Time Topic 10:00 MOSAIQ® SmartClinic 10:00 MOSAIQ® SmartClinic 10:00 Efficient management of brain metastases 10:15 MOSAIQ® VoiceAutomation 10:15 IBM Watson for Oncology 10:15 End-to-end stereotactic accuracy 11:00 MOSAIQ® Plaza Elek

Elekta Analyst meeting on 6ix